Standout Papers

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Respo... 1999 2026 2008 2017 8.8k
  1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib (2004)
    Thomas J. Lynch, Daphne W. Bell et al. New England Journal of Medicine
  2. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development (1999)
    Masaki Okano, Daphne W. Bell et al. Cell
  3. Isolation of rare circulating tumour cells in cancer patients by microchip technology (2007)
    Sunitha Nagrath, Lecia V. Sequist et al. Nature
  4. Epidermal growth factor receptor mutations in lung cancer (2007)
    Sreenath V. Sharma, Daphne W. Bell et al. Nature reviews. Cancer
  5. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (2004)
    Raffaella Sordella, Daphne W. Bell et al. Science
  6. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells (2008)
    Shyamala Maheswaran, Lecia V. Sequist et al. New England Journal of Medicine
  7. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib (2005)
    Eunice L. Kwak, Raffaella Sordella et al. Proceedings of the National Academy of Sciences
  8. salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines (2002)
    Nicolas Tapon, Kieran F. Harvey et al. Cell
  9. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas (1995)
    Alfonso Bellacosa, Andrew K. Godwin et al. International Journal of Cancer
  10. Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome (1999)
    Daphne W. Bell, Jennifer M. Varley et al. Science
  11. BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function (2001)
    Sharon B. Cantor, Daphne W. Bell et al. Cell
  12. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials (2005)
    Daphne W. Bell, Thomas J. Lynch et al. Journal of Clinical Oncology
  13. Clinical actionability of molecular targets in endometrial cancer (2019)
    Mary Ellen Urick, Daphne W. Bell Nature reviews. Cancer

Immediate Impact

3 by Nobel laureates 54 from Science/Nature 154 standout
Sub-graph 1 of 15

Citing Papers

Metabolic reprogramming and cancer progression
2020 StandoutScience
The biology and management of non-small cell lung cancer
2018 StandoutNature
12 intermediate papers

Works of Daphne W. Bell being referenced

Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Daphne W. Bell 16254 14308 13262 86 31.7k
Jeremy A. Squire 18211 13137 8023 377 33.2k
Charles L. Sawyers 24460 12045 15672 263 52.5k
Daniel J. Hicklin 20563 13904 5554 184 34.9k
Charles Swanton 12617 12369 8250 314 29.4k
Elizabeth A. Eisenhauer 11776 15013 12565 205 41.1k
Roger E. McLendon 19151 12748 5204 325 41.0k
David A. Tuveson 19285 20810 4694 200 40.1k
Warren Mason 10386 5614 7489 213 32.4k
Michael J. Eck 18019 12335 11015 156 32.0k
Johanna A. Joyce 11788 11468 3463 103 28.3k

All Works

Loading papers...

Rankless by CCL
2026